Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphOCYtic leukemia

Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphOCYtic leukemia

Aim. to analyze the efficacy of RFC (rituximab, fludarabine, and cyclophosphan), FCM (fludarabine, cyclophosphan, and mitoxantrone), and FC (fludarabine and cyclophosphan) treatment programs in patients with chronic lymphocytic leukemia (CLL) in an open-labeled comparative controlled investigation....

Full description

Bibliographic Details
Main Authors: Tamara Pavlovna Zagoskina, Sergey Borisovich Tkachenko, Marina Evgen'evna Golubeva, Alevtina Vasil'evna Kudryavtseva, Natal'ya Vasil'evna Isaeva, Ol'ga Viktorovna Malykh, T P Zagoskina, S B Tkachenko, M E Golubeva, A V Kudryavtseva, N V Isayeva, O V Malykh
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2010-03-01
Series:Терапевтический архив
Subjects:
chronic lymphocytic leukemia
chemotherapy
immunochemotherapy
fludarabine
cyclophosphan
rituximab
mitoxantrone
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/33386

Internet

https://ter-arkhiv.ru/0040-3660/article/view/33386

Similar Items